Summaries for Tauopathy

About this section


Disease Ontology:9 A neurodegenerative disease that has material basis in the pathological aggregation of tau protein in so-called neurofibrillary tangles (nft) in the human brain.

MalaCards based summary: Tauopathy, also known as tauopathies, is related to dementia and alzheimer disease. An important gene associated with Tauopathy is MAPT (microtubule-associated protein tau), and among its related pathways are Reelin Pathway (Cajal-Retzius cells) and IL-6 Signaling Pathway. The compound roscovitine have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and cortex.

Wikipedia:63 Tauopathies are a class of neurodegenerative diseases associated with the pathological aggregation of... more...

Aliases & Classifications for Tauopathy

About this section
Sources:
9Disease Ontology, 43Novoseek, 60UMLS, 33MeSH
See all sources

Tauopathy, Aliases & Descriptions:

Name: Tauopathy 9
 
Tauopathies 43 60


External Ids:

Disease Ontology9 DOID:680
MeSH33 D024801

Related Diseases for Tauopathy

About this section

Graphical network of the top 20 diseases related to Tauopathy:



Diseases related to tauopathy

Symptoms for Tauopathy

About this section

Drugs & Therapeutics for Tauopathy

About this section

Drug clinical trials:

Search ClinicalTrials for Tauopathy

Search NIH Clinical Center for Tauopathy

Genetic Tests for Tauopathy

About this section

Anatomical Context for Tauopathy

About this section

MalaCards organs/tissues related to Tauopathy:

31
Brain, Eye, Cortex, Retina, Testes

Animal Models for Tauopathy or affiliated genes

About this section

Publications for Tauopathy

About this section

Articles related to Tauopathy:

(show top 50)    (show all 357)
idTitleAuthorsYear
1
Truncated tau deregulates synaptic markers in rat model for human tauopathy. (25755633)
2015
2
Current trends in tauopathy research: from disease modelling to therapeutic approaches. (25630630)
2015
3
Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathy. (25756587)
2015
4
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. (24277722)
2014
5
Attenuation of I^-amyloid-induced tauopathy via activation of CK2I+/SIRT1: Targeting for cilostazol. (24254769)
2014
6
18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy. (25469232)
2014
7
Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach. (25225483)
2014
8
Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. (23478312)
2013
9
Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. (24319659)
2013
10
Neurodegenerative disease: can synucleinopathy and tauopathy be identified during life? (23857044)
2013
11
Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. (24362441)
2013
12
MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. (22723018)
2012
13
Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. (22874558)
2012
14
Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model. (21889983)
2012
15
Potential neuroprotective strategies against tauopathy. (22817711)
2012
16
Impedance spectroscopy based measurement system for quantitative and label-free real-time monitoring of tauopathy in hippocampal slice cultures. (22221799)
2012
17
Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy. (22169201)
2012
18
Is intractable epilepsy a tauopathy? (21440375)
2011
19
Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. (21976528)
2011
20
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. (21685912)
2011
21
Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity. (20882568)
2010
22
Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. (20943926)
2010
23
Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies. (20569300)
2010
24
Generation of tau aggregates and clearance by autophagy in an inducible cell model of tauopathy. (20173337)
2010
25
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. (20599975)
2010
26
A novel organotypic tauopathy model on a new microcavity chip for bioelectronic label-free and real time monitoring. (20591644)
2010
27
Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. (19717642)
2009
28
Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. (19238406)
2009
29
Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy. (19074615)
2009
30
Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathies. (18322396)
2008
31
Functional genomics dissects pathomechanisms in tauopathies: mitosis failure and unfolded protein response. (18322384)
2008
32
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. (17113760)
2007
33
Cytosine beta-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy. (17151917)
2007
34
Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies. (17089132)
2007
35
Rhodanine-based tau aggregation inhibitors in cell models of tauopathy. (17985339)
2007
36
Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis? (17318305)
2007
37
TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. (16461276)
2006
38
Neuropathology of familial tauopathy. (17080727)
2006
39
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. (17030663)
2006
40
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). (16291936)
2005
41
Unique tauopathy in Fukuyama-type congenital muscular dystrophy. (16319722)
2005
42
Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies. (15372253)
2004
43
Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies. (15541003)
2004
44
Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge]. (14646802)
2003
45
Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. (14572447)
2003
46
Hippocampal sclerosis dementia with tauopathy. (12946017)
2003
47
Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. (11447312)
2001
48
Neurodegenerative tauopathies. (11520930)
2001
49
Analysis of tauopathies with transgenic mice. (11597522)
2001
50
Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. (10595524)
1999

Variations for Tauopathy

About this section

Expression for genes affiliated with Tauopathy

About this section
Search GEO for disease gene expression data for Tauopathy.

Pathways for genes affiliated with Tauopathy

About this section

Compounds for genes affiliated with Tauopathy

About this section
Sources:
43Novoseek
See all sources

Compounds related to Tauopathy according to GeneCards Suite gene sharing:

idCompoundScoreTop Affiliating Genes
1roscovitine439.5CDK5R1, MAPT

GO Terms for genes affiliated with Tauopathy

About this section

Cellular components related to Tauopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1neuronal cell bodyGO:00430259.5CDK5R1, SNCB
2axonGO:00304249.2CDK5R1, MAPT
3growth coneGO:00304269.0CDK5R1, MAPT, SNCB

Biological processes related to Tauopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1neuron migrationGO:00017649.5CDK5R1, MAPT

Products for genes affiliated with Tauopathy

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Tauopathy

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet